134. Septo-optic dysplasia Disease details / Clinical trials / Drug dev / DR info /
Clinical trials : 2 / Drugs : 2 - (DrugBank : 1) / Drug target gene : 1 - Drug target pathways : 3
Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Nutropin AQ
Children's Hospital Los Angeles
2004 Phase 4 NCT00140413 United States
Setmelanotide
Rhythm Pharmaceuticals, Inc.
2025 Phase 3 NCT06760546 -
Children's Hospital Los Angeles
2004 Phase 4 NCT00140413 United States
Setmelanotide
Rhythm Pharmaceuticals, Inc.
2025 Phase 3 NCT06760546 -